Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease
- 18 December 2001
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 98 (26), 15215-15220
- https://doi.org/10.1073/pnas.221292098
Abstract
Plasma xanthine oxidase (XO) activity was defined as a source of enhanced vascular superoxide (O \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*}) and hydrogen peroxide (H2O2) production in both sickle cell disease (SCD) patients and knockout-transgenic SCD mice. There was a significant increase in the plasma XO activity of SCD patients that was similarly reflected in the SCD mouse model. Western blot and enzymatic analysis of liver tissue from SCD mice revealed decreased XO content. Hematoxylin and eosin staining of liver tissue of knockout-transgenic SCD mice indicated extensive hepatocellular injury that was accompanied by increased plasma content of the liver enzyme alanine aminotransferase. Immunocytochemical and enzymatic analysis of XO in thoracic aorta and liver tissue of SCD mice showed increased vessel wall and decreased liver XO, with XO concentrated on and in vascular luminal cells. Steady-state rates of vascular O \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*} production, as indicated by coelenterazine chemiluminescence, were significantly increased, and nitric oxide (⋅NO)-dependent vasorelaxation of aortic ring segments was severely impaired in SCD mice, implying oxidative inactivation of ⋅NO. Pretreatment of aortic vessels with the superoxide dismutase mimetic manganese 5,10,15,20-tetrakis(N-ethylpyridinium-2-yl)porphyrin markedly decreased O \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*} levels and significantly restored acetylcholine-dependent relaxation, whereas catalase had no effect. These data reveal that episodes of intrahepatic hypoxia-reoxygenation associated with SCD can induce the release of XO into the circulation from the liver. This circulating XO can then bind avidly to vessel luminal cells and impair vascular function by creating an oxidative milieu and catalytically consuming ⋅NO via O \begin{equation*}{\mathrm{_{2}^{{\cdot}-}}}\end{equation*}-dependent mechanisms.Keywords
This publication has 73 references indexed in Scilit:
- Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal miceJCI Insight, 2000
- Tissue factor expression by endothelial cells in sickle cell anemia.JCI Insight, 1998
- Knockout-Transgenic Mouse Model of Sickle Cell DiseaseScience, 1997
- Xanthine Oxidase Inhibition With Oxypurinol Improves Endothelial Vasodilator Function in Hypercholesterolemic but Not in Hypertensive PatientsHypertension, 1997
- Neutrophils obtained from obliterative atherosclerotic patients exhibit enhanced resting respiratory burst and increased degranulation in response to various stimuliBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1996
- The metabolites of nitric oxide in sickle‐cell diseaseBritish Journal of Haematology, 1995
- Distribution of xanthine oxidoreductase activity in human tissues — a histochemical and biochemical studyVirchows Archiv B Cell Pathology Including Molecular Pathology, 1993
- Potentiated adherence of sickle erythrocytes to endothelium infected by virus.JCI Insight, 1987
- Spontaneous oxygen radical generation by sickle erythrocytes.JCI Insight, 1982
- Cerebrovascular disease in sickle cell anemia: a clinical, pathological and radiological correlation.Stroke, 1978